-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Corteva, Lowers Price Target to $95

Benzinga·09/16/2026 13:09:50
Listen to the news
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $100 to $95.